Quick Overview: Saeed Sadeghi, MD, provides an overview of the current standard of care when In this episode, Dr Neil Love hosts a roundtable discussion on the efficacy and toxicity of approved and emerging Chair, Milind Javle, MD, Mitesh J. Borad, MD, Aiwu Ruth He, MD, PhD, and Flavio G. Rocha, MD, FACS, FSSO, discuss biliary ...
Optimizing Therapy For Advanced Cholangiocarcinoma - Detailed Overview & Context
Saeed Sadeghi, MD, provides an overview of the current standard of care when In this episode, Dr Neil Love hosts a roundtable discussion on the efficacy and toxicity of approved and emerging Chair, Milind Javle, MD, Mitesh J. Borad, MD, Aiwu Ruth He, MD, PhD, and Flavio G. Rocha, MD, FACS, FSSO, discuss biliary ... Saeed Sadeghi, MD, comments on the FDA approval of pemigatinib and the fast-track designation for infigratinib as Dr. Lipika Goyal provides an overview of the actionable targets in Saeed Sadeghi, MD, discusses the mechanisms of action of current FGFR2 inhibitors for
Lorenza Rimassa, MD, Hunimed University, Milan, Italy, discusses A discussion on the importance of NGS (next-generation sequencing) and molecular testing in Lorenza Rimassa, MD, Humanitas University and IRCCS Humanitas Research Hospital, Milan, Italy, discusses recent positive ... Chair Milind Javle, MD, discusses Biliary Cancers in this CME activity titled “A New Dawn in the Eugene Koay is an associate professor in the Department of GI Radiation Oncology at MD Anderson Cancer Center. Lorenza Rimassa, MD, Humanitas University and IRCCS Humanitas Research Hospital, Milan, Italy, explains the basics of ...
Lorenza Rimassa, MD, Humanitas University, Milan, Italy, comments on the development of targeted Rachna T. Shroff, MD, MS, chief, Section of GI Medical Oncology, University of Arizona Cancer Center, says that when and if a ... ... just here but from around the country here in the United States for uh
